United States

CDMO News

Restore Vision Partners with Forge Biologics to Advance RV-001 Gene Therapy

22 July 2026

CDMO News

Aptyx Appoints David Price as Chief Executive Officer

21 July 2026

Policy Briefing

Congress Proposes Federal Oversight for US-China Drug Licensing Deals

4 June 2026

Podcast

How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai

9 February 2026

Manufacturing News

AstraZeneca Lists on NYSE, Ending ADS Program

2 February 2026

Policy Briefing

RFK Jr’s Vaccine Panel Expected to Delay Newborn Hepatitis B Shots Until Age 4

16 September 2025

Expert Insight

Biodefense Policy Leaders Call for Industry to Step Up Congressional Engagement as Legislative Champions Exit

16 June 2025

Podcast

Perfect Storm for US Drug Manufacturing as FDA Changes, Trade Wars and M&A Surge Collide

6 February 2025

Spotlight

Lannett CDMO: Contract Manufacturing with Heritage

15 October 2023

Manufacturing

Trend Briefing: “China-Proofing” the Pharma Supply Chain

3 September 2023